GenScript USA Responds to Monkeypox Public-Health Emergency with Real-Time PCR Test
PISCATAWAY, N.J., Aug. 18, 2022 /PRNewswire/ -- GenScript USA Inc., a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading biotechnology company, announced the immediate availability of a monkeypox virus PCR test kit. The kit, which was developed in partnership with Anbio Biotechnology, can be ordered today by diagnostic labs and medical device distributors to be used in research to provide detection of the monkeypox virus. The test kit has already received the CE mark for IVD use in the European Union (EU).